Year in Review: 2022

A Note from Rheumatology Leadership

The Division of Rheumatology and Clinical Immunology has a tradition of excellence in patient care, education, and research for over fifty years. Our clinical activities emphasize care of both common and rare rheumatic diseases. We have outpatient clinics devoted to all types of autoimmune diseases and musculoskeletal disorders. Our faculty have a wide range of clinical and research interests, with specific expertise in systemic lupus erythematosus, myositis, vasculitis, scleroderma, and autoinflammatory disorders.

We are committed to a mission of providing the highest quality care for patients with autoimmune and inflammatory diseases and mentoring and training medical students, residents, fellows, and young faculty.

Remarkable advances in drug discovery, mechanisms of disease, epidemiology, outcome research, and other related fields make a career in academic rheumatology an exciting career opportunity. The University of Pittsburgh and UPMC have a long tradition of multidisciplinary collaboration. The faculty in the Division of Rheumatology, combined with cutting-edge clinical, educational, and patient care resources, provide for ongoing success of rheumatology at the University of Pittsburgh.

We welcome the opportunity to tell you more about our efforts in 2022 and invite you to learn more about our exceptional team of faculty, fellows, and residents and our various clinical, research, and educational programs and hope you'll consider voting for UPMC Presbyterian Shadyside in the upcoming U.S. News & World Report "Best Hospitals" survey.